CMND gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 190 industry peers in the Pharmaceuticals industry. While CMND seems to be doing ok healthwise, there are quite some concerns on its profitability. CMND is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year CMND has reported negative net income.
In the past year CMND has reported a negative cash flow from operations.
In the past 5 years CMND always reported negative net income.
CMND had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

CMND has a Return On Assets of -101.99%. This is in the lower half of the industry: CMND underperforms 78.95% of its industry peers.
CMND has a worse Return On Equity (-378.42%) than 77.37% of its industry peers.

		Industry Rank	Sector Rank
ROA	-101.99%
ROE	-378.42%
ROIC	N/A

ROA(3y)-350.52%

ROA(5y)-233.83%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CMND does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for CMND has been increased compared to 1 year ago.
The number of shares outstanding for CMND has been reduced compared to 5 years ago.
Compared to 1 year ago, CMND has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 20.27 indicates that CMND is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 20.27, CMND belongs to the top of the industry, outperforming 87.37% of the companies in the same industry.
There is no outstanding debt for CMND. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	20.27

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

CMND has a Current Ratio of 1.32. This is a normal value and indicates that CMND is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.32, CMND is doing worse than 75.79% of the companies in the same industry.
CMND has a Quick Ratio of 1.32. This is a normal value and indicates that CMND is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CMND (1.32) is worse than 68.95% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.32
Quick Ratio	1.32

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for CMND have decreased strongly by -102.96% in the last year.

EPS 1Y (TTM)-102.96%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1567.05%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.